Stroke Prevention: Exploring New Targets in Blood Clotting | Science Is Boss @BayerGlobal
Stroke Prevention: Exploring New Targets in Blood Clotting | Science Is Boss  @BayerGlobal
Uploaded October 2026 | Updated November 2026, 15 hours ago
How do you design a new medicine in stroke prevention?

In this episode of Science Is Boss, Bayer CEO Bill Anderson sits down with Bayer scientist Stefan Heitmeier to explore this decades-long scientific journey.

From testing thousands of molecules to pursuing a novel target, Stefan shares what it takes to turn a scientific hypothesis into a potential medicine. The conversation offers a rare look at the persistence, teamwork, and innovation that drive drug discovery.

In this episode:

- Why stroke prevention remains a critical unmet medical need

- How scientists searched through thousands of molecules to find the right candidate

- What it takes to advance from idea to development

Innovation in healthcare is rarely a straight path. Stefan's story is a powerful reminder of the dedication behind the search for new treatment options for patients.

#HealthForAll #HungerForNone
Stroke Prevention: Exploring New Targets in Blood Clotting | Science Is BossAMD and Vision Loss: Annas Story in Ophthalmology | BayerBayerTalks with Chitkala Kalidas | Sustainable Growth, AI & Indias Opportunity to Shape the FutureBayer Glyphosate Litigation Update with CEO Bill AndersonTraining, Yields and Economic Opportunity Through Better Life Farming | BayerMeet the People Behind #TeamBayer Oncology | BayerCelebrating 25 Years of Serenade | Biologicals by BayerFirst-Quarter 2025 Results in 90 Seconds with Bayer CEO Bill Anderson | BayerFrom teacher to smallholder farmer in Kenya: Moses Munya’s story2026 Annual Stockholders Meeting | Bayer Results and Strategy with CEO Bill AndersonAI Innovation at Bayer: CEO Bill Anderson Shows How 600 Colleagues Build Solutions in One DaySustainable Farming at Selterhof: The Bohnsack Family’s Journey Through Tradition and Modernity
Bayer Global |

Stroke Prevention: Exploring New Targets in Blood Clotting | Science Is Boss

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER